Naples, Italy

Andrea Ballabio

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Napoli, IT (2015)
  • Naples, IT (2010 - 2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Andrea Ballabio: Innovator in Gene Therapy

Introduction

Andrea Ballabio is a prominent inventor based in Naples, Italy. She has made significant contributions to the field of gene therapy, particularly in the treatment of mucopolysaccharidoses. With a total of 6 patents to her name, her work has the potential to transform therapeutic strategies for central nervous system (CNS) pathologies.

Latest Patents

Among her latest patents is a groundbreaking invention that provides nucleotide sequences encoding for a chimeric sulfatase. This invention also includes viral vectors that express these sequences for gene therapy and outlines pharmaceutical uses of the chimeric expressed protein. The invention is particularly focused on the therapy of mucopolysaccharidosis, preferably type IIIA. This innovative approach aims to address the challenges faced by patients suffering from this condition.

Career Highlights

Throughout her career, Andrea has worked with notable organizations such as Fondazione Telethon and Shire Human Genetic Therapies, Inc. Her work in these institutions has allowed her to advance her research and contribute to the development of effective therapies for genetic disorders.

Collaborations

Andrea has collaborated with esteemed colleagues, including Alessandro Fraldi and Carmine Settembre. These partnerships have enriched her research and expanded the impact of her inventions in the field of gene therapy.

Conclusion

Andrea Ballabio stands out as an influential inventor in the realm of gene therapy, with her innovative patents paving the way for new treatment options for mucopolysaccharidoses. Her dedication to advancing medical science continues to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…